Related Experiment Video

Updated: May 31, 2026

DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat (VNTR) - Fragment Length Analysis (FLA)
09:39

DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat (VNTR) - Fragment Length Analysis (FLA)

Published on: July 15, 2011

Interleukin 4-590T/C polymorphism and susceptibility to leprosy

Degang Yang1, Haihan Song, Weimin Xu

  • 1Department of Infectious Diseases, Shanghai Skin Disease Hospital, 1278 Bao De Road, Shanghai, China.

Genetic Testing and Molecular Biomarkers
|July 14, 2011
PubMed

Insights

The Interleukin 4 (IL-4) gene -590T/C polymorphism is linked to reduced leprosy susceptibility in Chinese individuals. This genetic variation may offer protective effects against the infectious disease.

Area of Science:

  • Genetics
  • Immunology
  • Infectious Diseases

Background:

  • Leprosy is a chronic infectious disease caused by Mycobacterium leprae.
  • The balance between T-helper 1 (Th1) and T-helper 2 (Th2) immune responses is crucial in leprosy.
  • Interleukin 4 (IL-4), a key Th2 cytokine, plays a significant role in modulating this immune balance.

Purpose of the Study:

  • To investigate the association between the IL-4 gene -590T/C polymorphism and leprosy susceptibility.
  • To analyze the role of IL-4 genetic variations in the immune response to Mycobacterium leprae infection in a Chinese population.

Main Methods:

  • Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to genotype the IL-4 -590T/C variant.
  • The study included 432 leprosy patients and 465 age-matched healthy controls from a Chinese population.
  • Chi-square tests were employed for statistical analysis of genotype and allele frequencies.

Main Results:

  • Frequencies of the IL-4-590TC and CC genotypes were significantly lower in leprosy patients compared to healthy controls (OR=0.74, P=0.044; OR=0.46, P=0.010).
  • The -590C allele frequency was also significantly reduced in leprosy cases (OR=0.68, P=0.001).
  • These findings indicate a protective association of certain IL-4 genotypes and alleles against leprosy.

Conclusions:

  • The IL-4 gene -590T/C polymorphism is associated with decreased susceptibility to leprosy in the studied Chinese population.
  • This genetic variation may influence the immune response, potentially offering protection against Mycobacterium leprae infection.
  • Further research can explore the functional implications of this polymorphism in leprosy pathogenesis.
Abstract

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...